B. Duque

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 386 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System

Elena Ramı́rez, Olga Laosa, Pedro Ignacio Cardona Guerra et al. · British Journal of Clinical Pharmacology · 2010 · 82 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

PHASE I PHARMACOKINETIC STUDY OF A SINGLE INTRAVESICAL INSTILLATION OF GEMCITABINE ADMINISTERED IMMEDIATELY AFTER TRANSURETHRAL RESECTION PLUS MULTIPLE RANDOM BIOPSIES IN PATIENTS WITH SUPERFICIAL BLADDER CANCER

Juan Palou, Antonio J. Carcas, B. Duque et al. · The Journal of Urology · 2004 · 34 citations

Medicine, Oncology, Urology +13

The importance of sample size, log-mean ratios, and intrasubject variability in the acceptance criteria of 108 bioequivalence studies

P. Guerra, Olga Laosa, B. Duque et al. · European Journal of Clinical Pharmacology · 2008 · 10 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17